.png)
Bisphosphonates Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 159 Category: Pharma & Healthcare Report Code : HC0114585
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Bisphosphonates Market By Type (Alendronate, Ibandronate, Risedronate, Zoledronic Acid) and Application (Metastatic Bone Cancer, Systemic Metabolic Bone Diseases)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Bisphosphonates Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Bisphosphonates are a family of drugs used to treat osteoporosis. Bisphosphonates bind to the surfaces of the bones and slow down the bone resorping action of the osteoclasts and allows the osteoblasts (bone-building cells) to work more effectively.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Bisphosphonates Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Merck
- Teva
- Mylan
- Apotex Corp
- Pfizer
- Sanofi
- Roche
- Novartis
- Eli Lilly
- Amgen
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Bisphosphonates Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Alendronate
o Ibandronate
o Risedronate
o Zoledronic Acid
· Bisphosphonates Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Metastatic Bone Cancer
o Systemic Metabolic Bone Diseases
· Bisphosphonates Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Merck
o Teva
o Mylan
o Apotex Corp
o Pfizer
o Sanofi
o Roche
o Novartis
o Eli Lilly
o Amgen
· Bisphosphonates Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Bisphosphonates Market, By Country
o U.S. Bisphosphonates Market
o Canada Bisphosphonates Market
o Mexico Bisphosphonates Market
o Europe
§ Europe Bisphosphonates Market, By Country
o UK Bisphosphonates Market
o Germany Bisphosphonates Market
o France Bisphosphonates Market
o Russia Bisphosphonates Market
o Italy Bisphosphonates Market
o Rest of Europe Bisphosphonates Market
o Asia-Pacific
§ Asia-Pacific Bisphosphonates Market, By Country
o China Bisphosphonates Market
o Japan Bisphosphonates Market
o South Korea Bisphosphonates Market
o India Bisphosphonates Market
o Southeast Asia Bisphosphonates Market
o Rest of Asia-Pacific Bisphosphonates Market
o South America
§ South America Bisphosphonates Market
o Brazil Bisphosphonates Market
o Argentina Bisphosphonates Market
o Columbia Bisphosphonates Market
o Rest of South America Bisphosphonates Market
o Middle East and Africa
§ Middle East and Africa Bisphosphonates Market
o Saudi Arabia Bisphosphonates Market
o UAE Bisphosphonates Market
o Egypt Bisphosphonates Market
o Nigeria Bisphosphonates Market
o South Africa Bisphosphonates Market
o TurkeyBisphosphonates Market
o Rest of MEA Bisphosphonates Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Bisphosphonates Market, By Type
5.1. Introduction
5.2. Global Bisphosphonates Revenue and Market Share by Type (2017-2021)
5.2.1. Global Bisphosphonates Revenue and Revenue Share by Type (2017-2021)
5.3. Alendronate
5.3.1. Global Alendronate Revenue and Growth Rate (2017-2021)
5.4. Ibandronate
5.4.1. Global Ibandronate Revenue and Growth Rate (2017-2021)
5.5. Risedronate
5.5.1. Global Risedronate Revenue and Growth Rate (2017-2021)
5.6. Zoledronic Acid
5.6.1. Global Zoledronic Acid Revenue and Growth Rate (2017-2021)
6. Bisphosphonates Market, By Applications
6.1. Introduction
6.2. Global Bisphosphonates Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Bisphosphonates Revenue and Revenue Share by Applications (2017-2021)
6.3. Metastatic Bone Cancer
6.3.1. Global Metastatic Bone Cancer Revenue and Growth Rate (2017-2021)
6.4. Systemic Metabolic Bone Diseases
6.4.1. Global Systemic Metabolic Bone Diseases Revenue and Growth Rate (2017-2021)
7. Bisphosphonates Market, By Region
7.1. Introduction
7.2. Global Bisphosphonates Revenue and Market Share by Regions
7.2.1. Global Bisphosphonates Revenue by Regions (2017-2021)
7.3. North America Bisphosphonates by Countries
7.3.1. North America Bisphosphonates Revenue and Growth Rate (2017-2021)
7.3.2. North America Bisphosphonates Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Bisphosphonates by Countries
7.4.1. Europe Bisphosphonates Revenue and Growth Rate (2017-2021)
7.4.2. Europe Bisphosphonates Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Bisphosphonates by Countries
7.5.1. Asia-Pacific Bisphosphonates Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Bisphosphonates Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Bisphosphonates by Countries
7.6.1. South America Bisphosphonates Revenue and Growth Rate (2017-2021)
7.6.2. South America Bisphosphonates Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Bisphosphonates by Countries
7.7.1. Middle East and Africa Bisphosphonates Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Bisphosphonates Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Merck
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Teva
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Mylan
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Apotex Corp
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Pfizer
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Sanofi
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Novartis
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Novartis
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Eli Lilly
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Amgen
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Bisphosphonates Market Forecast (2022-2027)
9.1. Global Bisphosphonates Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Bisphosphonates Market Forecast by Regions (2022-2027)
9.2.1. North America Bisphosphonates Market Forecast (2022-2027)
9.2.1.1. United States Bisphosphonates Market Forecast (2022-2027)
9.2.1.2. Canada Bisphosphonates Market Forecast (2022-2027)
9.2.1.3. Mexico Bisphosphonates Market Forecast (2022-2027)
9.2.2. Europe Bisphosphonates Market Forecast (2022-2027)
9.2.2.1. Germany Bisphosphonates Market Forecast (2022-2027)
9.2.2.2. France Bisphosphonates Market Forecast (2022-2027)
9.2.2.3. UK Bisphosphonates Market Forecast (2022-2027)
9.2.2.4. Russia Bisphosphonates Market Forecast (2022-2027)
9.2.2.5. Italy Bisphosphonates Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Bisphosphonates Market Forecast (2022-2027)
9.2.3. Asia-Pacific Bisphosphonates Market Forecast (2022-2027)
9.2.3.1. China Bisphosphonates Market Forecast (2022-2027)
9.2.3.2. Japan Bisphosphonates Market Forecast (2022-2027)
9.2.3.3. Korea Bisphosphonates Market Forecast (2022-2027)
9.2.3.4. India Bisphosphonates Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Bisphosphonates Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Bisphosphonates Market Forecast (2022-2027)
9.2.4. South America Bisphosphonates Market Forecast (2022-2027)
9.2.4.1. Brazil Bisphosphonates Market Forecast (2022-2027)
9.2.4.2. Argentina Bisphosphonates Market Forecast (2022-2027)
9.2.4.3. Columbia Bisphosphonates Market Forecast (2022-2027)
9.2.4.4. Rest of South America Bisphosphonates Market Forecast (2022-2027)
9.2.5. Middle East and Africa Bisphosphonates Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Bisphosphonates Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Bisphosphonates Market Forecast (2022-2027)
9.2.5.3. Egypt Bisphosphonates Market Forecast (2022-2027)
9.2.5.4. Nigeria Bisphosphonates Market Forecast (2022-2027)
9.2.5.5. South Africa Bisphosphonates Market Forecast (2022-2027)
9.2.5.6. Turkey Bisphosphonates Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Bisphosphonates Market Forecast (2022-2027)
9.3. Bisphosphonates Market Forecast by Type (2022-2027)
9.3.1. Bisphosphonates Forecast by Type (2022-2027)
9.3.2. Bisphosphonates Market Share Forecast by Type (2022-2027)
9.4. Bisphosphonates Market Forecast by Applications (2022-2027)
9.4.1. Bisphosphonates Forecast by Applications (2022-2027)
9.4.2. Bisphosphonates Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Bisphosphonates Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Bisphosphonates Revenue and Revenue Share by Type (2017-2019)
Figure Global Alendronate Revenue and Growth Rate (2017-2019)
Figure Global Ibandronate Revenue and Growth Rate (2017-2019)
Figure Global Risedronate Revenue and Growth Rate (2017-2019)
Figure Global Zoledronic Acid Revenue and Growth Rate (2017-2019)
Table Global Bisphosphonates Revenue and Revenue Share by Applications (2017-2019)
Figure Global Metastatic Bone Cancer Revenue and Growth Rate (2017-2019)
Figure Global Systemic Metabolic Bone Diseases Revenue and Growth Rate (2017-2019)
Table Global Bisphosphonates Revenue by Regions (2017-2019)
Figure North America Bisphosphonates Growth Rate (2017-2019)
Figure North America Bisphosphonates Revenue and Growth Rate (2017-2019)
Figure North America Bisphosphonates by Countries (2017-2019)
Figure North America Bisphosphonates Revenue (Million USD) by Countries (2017-2019)
Figure United States Bisphosphonates Growth Rate (2017-2019)
Figure United States Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Bisphosphonates Growth Rate (2017-2019)
Figure Canada Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Bisphosphonates Growth Rate (2017-2019)
Figure Mexico Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Bisphosphonates Growth Rate (2017-2019)
Figure Europe Bisphosphonates Revenue and Growth Rate (2017-2019)
Figure Europe Bisphosphonates by Countries (2017-2019)
Figure Europe Bisphosphonates Revenue (Million USD) by Countries (2017-2019)
Figure Germany Bisphosphonates Growth Rate (2017-2019)
Figure Germany Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Bisphosphonates Growth Rate (2017-2019)
Figure France Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Bisphosphonates Growth Rate (2017-2019)
Figure UK Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Bisphosphonates Growth Rate (2017-2019)
Figure Russia Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Bisphosphonates Growth Rate (2017-2019)
Figure Italy Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Bisphosphonates Growth Rate (2017-2019)
Figure Rest of Europe Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Bisphosphonates Growth Rate (2017-2019)
Figure Asia-Pacific Bisphosphonates Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Bisphosphonates by Countries (2017-2019)
Figure Asia-Pacific Bisphosphonates Revenue (Million USD) by Countries (2017-2019)
Figure China Bisphosphonates Growth Rate (2017-2019)
Figure China Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Bisphosphonates Growth Rate (2017-2019)
Figure Japan Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Bisphosphonates Growth Rate (2017-2019)
Figure Korea Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Bisphosphonates Growth Rate (2017-2019)
Figure India Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Bisphosphonates Growth Rate (2017-2019)
Figure Southeast Asia Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Bisphosphonates Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Bisphosphonates Growth Rate (2017-2019)
Figure South America Bisphosphonates Revenue and Growth Rate (2017-2019)
Figure South America Bisphosphonates by Countries (2017-2019)
Figure South America Bisphosphonates Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Bisphosphonates Growth Rate (2017-2019)
Figure Brazil Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Bisphosphonates Growth Rate (2017-2019)
Figure Argentina Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Bisphosphonates Growth Rate (2017-2019)
Figure Columbia Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Bisphosphonates Growth Rate (2017-2019)
Figure Rest of South America Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Bisphosphonates Growth Rate (2017-2019)
Figure Middle East and Africa Bisphosphonates Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Bisphosphonates by Countries (2017-2019)
Figure Middle East and Africa Bisphosphonates Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Bisphosphonates Growth Rate (2017-2019)
Figure Saudi Arabia Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Bisphosphonates Growth Rate (2017-2019)
Figure United Arab Emirates Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Bisphosphonates Growth Rate (2017-2019)
Figure Egypt Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Bisphosphonates Growth Rate (2017-2019)
Figure Nigeria Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Bisphosphonates Growth Rate (2017-2019)
Figure South Africa Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Bisphosphonates Growth Rate (2017-2019)
Figure Turkey Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Bisphosphonates Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Bisphosphonates Revenue (Millions USD) and Growth Rate (2017-2019)
Table Merck Bisphosphonates Financial Overview
Table Teva Bisphosphonates Financial Overview
Table Mylan Bisphosphonates Financial Overview
Table Apotex Corp Bisphosphonates Financial Overview
Table Pfizer Bisphosphonates Financial Overview
Table Sanofi Bisphosphonates Financial Overview
Table Novartis Bisphosphonates Financial Overview
Table Novartis Bisphosphonates Financial Overview
Table Eli Lilly Bisphosphonates Financial Overview
Table Amgen Bisphosphonates Financial Overview
Figure Global Bisphosphonates Revenue (Millions USD) and Growth Rate (2019-2027)
Table Bisphosphonates Market Forecast by Regions (2019-2027)
Figure North America Bisphosphonates Market Forecast (2019-2027)
Figure United States Bisphosphonates Market Forecast (2019-2027)
Figure Canada Bisphosphonates Market Forecast (2019-2027)
Figure Mexico Bisphosphonates Market Forecast (2019-2027)
Figure Europe Bisphosphonates Market Forecast (2019-2027)
Figure Germany Bisphosphonates Market Forecast (2019-2027)
Figure France Bisphosphonates Market Forecast (2019-2027)
Figure UK Bisphosphonates Market Forecast (2019-2027)
Figure Russia Bisphosphonates Market Forecast (2019-2027)
Figure Italy Bisphosphonates Market Forecast (2019-2027)
Figure Rest of Europe Bisphosphonates Market Forecast (2019-2027)
Figure Asia-Pacific Bisphosphonates Market Forecast (2019-2027)
Figure China Bisphosphonates Market Forecast (2019-2027)
Figure Japan Bisphosphonates Market Forecast (2019-2027)
Figure Korea Bisphosphonates Market Forecast (2019-2027)
Figure India Bisphosphonates Market Forecast (2019-2027)
Figure Southeast Asia Bisphosphonates Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Bisphosphonates Market Forecast (2019-2027)
Figure South America Bisphosphonates Market Forecast (2019-2027)
Figure Brazil Bisphosphonates Market Forecast (2019-2027)
Figure Argentina Bisphosphonates Market Forecast (2019-2027)
Figure Columbia Bisphosphonates Market Forecast (2019-2027)
Figure Rest of South America Bisphosphonates Market Forecast (2019-2027)
Figure Middle East and Africa Bisphosphonates Market Forecast (2019-2027)
Figure Saudi Arabia Bisphosphonates Market Forecast (2019-2027)
Figure United Arab Emirates Bisphosphonates Market Forecast (2019-2027)
Figure Egypt Bisphosphonates Market Forecast (2019-2027)
Figure Nigeria Bisphosphonates Market Forecast (2019-2027)
Figure South Africa Bisphosphonates Market Forecast (2019-2027)
Figure Turkey Bisphosphonates Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Bisphosphonates Market Forecast (2019-2027)
Figure Global Bisphosphonates Forecast by Type (2019-2027)
Figure Global Bisphosphonates Market Share Forecast by Type (2019-2027)
Figure Global Bisphosphonates Forecast by Type (2019-2027)
Figure Global Bisphosphonates Forecast by Applications (2019-2027)
Figure Global Bisphosphonates Market Share Forecast by Applications (2019-2027)
Figure Global Bisphosphonates Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|